Hopefully some good news regarding Evesheld 2

https://www.astrazeneca-us.com/media/statements/2022/first-participant-dosed-in-supernova-phase-I-III-trial-evaluating-azd5156-a-next-generation-long-acting-antibody-combination-for-prevention-of-covid-19.html

1 Like

Hi @Marysheffield a great big welcome to our forum and I really look forward to hearing more about you.
Look after yourself